nach oben

Erschienen in:

05.11.2020 | Varikosis | Leitlinien und Empfehlungen

Leitlinie Sklerosierungsbehandlung der Varikose

S2k-Leitlinie der Deutschen Gesellschaft für Phlebologie (DGP) in Kooperation mit folgenden Fachgesellschaften: DDG, DGA, DGG, BVP

verfasst von: Prof. Dr. med. E. Rabe, F. X. Breu, I. Flessenkämper, H. Gerlach, S. Guggenbichler, B. Kahle, R. Murena, S. Reich-Schupke, T. Schwarz, Prof. Dr. med. M. Stücker, E. Valesky, S. Werth, F. Pannier

Erschienen in: Die Dermatologie | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Auszug

Bei der Sklerosierungsbehandlung handelt es sich um die gezielte chemische Ablation von Varizen durch die intravenöse Injektion eines flüssigen oder aufgeschäumten Sklerosierungsmittels [1, 2]. Die zu behandelnden Venen können intradermal, subkutan und/oder transfaszial (Perforansvenen) sowie als epi-, supra- und subfasziale Gefäße bei venösen Malformationen vorliegen. Das Sklerosierungsmittel zerstört das venöse Endothel und evtl. weitere Bereiche der Venenwand und wird durch Blutbestandteile und zirkulierende Zellen inaktiviert [1, 2]. Nach erfolgreicher Sklerosierung kommt es längerfristig zur Umwandlung der Varizen in einen bindegewebigen Strang, einem als Sklerose bekannten Prozess [3‐6]. Ziel der Sklerosierungsbehandlung ist nicht die Thrombosierung der Venen, da die behandelten Venen rekanalisieren könnten, sondern die definitive Transformation der thrombosierten Vene in einen Bindegewebsstrang. Dieser kann nicht rekanalisieren und entspricht in seinem funktionellen Ergebnis der operativen Entfernung einer Varize oder der endovenösen thermischen Ablation. …

Rabe E, Breu FX, Cavezzi A, Coleridge Smith P, Frullini A, Gillet JL, Guex JJ, Hamel-Desnos C, Kern P, Partsch B, Ramelet AA, Tessari L, Pannier F, Guideline Group (2014) European guidelines for sclerotherapy in chronic venous disorders. Phlebology 29:338–354PubMedCrossRef

Connor DE, Cooley-Andrade O, Goh WX, Ma DDF, Parsi K (2015) Detergent sclerosants are deactivated and consumed by circulating blood cells. Eur J Vasc Endovasc Surg 49:426–431PubMedCrossRef

Drake LA, Dinehart SM, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Franceschi C (1996) Guidelines of care for sclerotherapy treatment of varicose and teleangiectatic leg veins. J Am Acad Dermatol 34:523–528CrossRef

Rabe E, Pannier-Fischer F, Gerlach H, Breu FX, Guggenbichler S, Zabel M, German Society of Phlebology (2004) Guidelines for sclerotherapy of varicose veins. Dermatol Surg 30:687–693PubMed

Hamel-Desnos C, Ouvry P, Benigni JP, Boitelle G, Schadeck M, Desnos P, Allaert FA (2007) Comparison of 1 % and 3 % polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. “the 3/1 study”. Eur J Vasc Endovasc Surg 34:723–729PubMedCrossRef

Chen C‑H, Chiu C‑S, Yang C‑H (2012) Ultrasound-guided foam sclerotherapy for treating incompetent great saphenous veins—results of 5 years of analysis and morphologic evolvement study. Dermatol Surg 38:851–857PubMedCrossRef

Hamel-Desnos C, Desnos P, Wollmann JC, Quvry P, Mako S, Allaert FA (2003) Evaluation of the efficacy of Polidocanol in the form of foam compared with liquid form in sclerotherapy of the long saphenous vein: Initial results. Dermatol Surg 29:1170–1175PubMed

Alòs J, López JA, Estadella B, Serra-Prat M, Marinel-Lo J (2006) Efficacy and safety of sclerotherapy using Polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 31:101–107PubMedCrossRef

Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C (2008) Efficacy of polidocanol foam versus liquid in Sclerotherapy of the great Saphenous vein: a multicenter randomised controlled trial with a 2-year follow-up. Eur J Vasc Surg 36:366–370CrossRef

10.

Rabe E, Otto J, Schliephake D, Pannier F (2008) Efficacy and safety of great Saphenous vein Sclerotherapy using Standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial. Eur J Endovasc Vasc Surg 35:238–245CrossRef

11.

Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B (2011) Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg 98:1079–1087PubMedCrossRef

12.

Shadid N, Ceulen R, Nelemans P, Dirksen C, Veraart J, Schurink GW, van Neer P, Vd Kley J, de Haan E, Sommer A (2012) Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein. Br J Surg 99:1062–1070PubMedCrossRef

13.

Williamsson C, Danielsson P, Smith L (2013) Catheter-directed foam sclerotherapy for insufficiency of the great saphenous vein: occlusion rates and patient satisfaction after one year. Phlebology 28:80–85PubMedCrossRef

14.

Davies HO, Popplewell M, Darvall K, Bate G, Bradbury AW (2016) A review of randomized controlled trials comparing ultrasound-guided foam sclerotherapy with endothermal ablation for the treatment of great saphenous varicose veins. Phlebology 31:234–240PubMedCrossRef

15.

Venermo M, Saarinen J, Eskelinen E, Vähäaho S, Saarinen E, Railo M, Uurto I, Salenius J, Albäck A, Finnish Venous Study Collaborators (2016) Randomized clinical trial comparing surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy for the treatment of great saphenous varicose veins. Br J Surg 103:1438–1444PubMedPubMedCentralCrossRef

16.

Lawaetz M, Serup J, Lawaetz B, Bjoern L, Blemings A, Eklof B, Rasmussen L (2017) Comparison of endovenous ablation techniques, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Extended 5‑year follow-up of a RCT. Int Angiol 36:281–288PubMed

17.

Brittenden J, Cotton SC, Elders A, Tassie E, Scotland G, Ramsay CR, Norrie J, Burr J, Francis J, Wileman S, Campbell B, Bachoo P, Chetter I, Gough M, Earnshaw J, Lees T, Scott J, Baker SA, MacLennan G, Prior M, Bolsover D, Campbell MK (2015) Clinical effectiveness and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technol Assess 19:1–342PubMedPubMedCentralCrossRef

18.

Van der Velden SK, Biemans A, De Maeseneer M, Kockaert MA, Cuypers PW, Hollestein LM, Neumann HAM, Nijsten T, van den Bos RR (2015) Five-year results of a randomized clinical trial of conventional surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy in patients with great saphenous varicose veins. Br J Surg 102:1184–1194PubMedCrossRef

19.

Myers KA, Jolley D, Clough A, Kirwan J (2007) Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 33:116–121PubMedCrossRef

20.

Zhang J, Jing Z, Schliephake DE, Otto J, Malouf GM, Gu YQ (2012) Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5 %, 1 % and 3 % in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study). Phlebology 27:184–190PubMedCrossRef

21.

Guex JJ (2000) Ultrasound guided Sclerotherapy (USGS) for perforating veins. Hawaii Med J 59:261–262PubMed

22.

Masuda EM, Kessler DM, Lurie F, Puggioni A, Kistner RL, Eklof B (2006) The effect of ultrasound guided sclerotherapy of incompetent perforator veins on venous clinical severity scores. J Vasc Surg 43:551–556PubMedCrossRef

23.

Van Neer P, Veraart JCJM, Neumann H (2006) Posterolateral thigh perforator varicosities in 12 patients: a normal deep venous system and successful treatment with ultrasound-guided sclerotherapy. Dermatol Surg 32:1346–1352PubMed

24.

Guzelmansur I, Oguzkurt L, Koca N, Andic C, Gedikoglu M, Ozkan U (2014) Endovenous laser ablation and sclerotherapy for incompetent vein of Giacomini. Phlebology 29(8):511–516PubMedCrossRef

25.

Kahle B, Leng K (2004) Efficacy of sclerotherapy in varicose veins—a prospective, blinded placebocontrolled study. Dermatol Surg 30:723–728PubMed

26.

Norris MJ, Carlin MC, Ratz JL (1989) Treatment of essential telangiectasias: effects of increasing concentrations of polidocanol. J Am Acad Dermatol 20:643–649PubMedCrossRef

27.

Rabe E, Schliephake D, Otto J, Breu FX, Pannier F (2010) Sclerotherapy of telangiectasias and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). Phlebology 25:124–131PubMedCrossRef

28.

Uncu H (2010) Sclerotherapy: a study comparing polidocanol in foam and liquid form. Phlebology 25:44–49PubMedCrossRef

29.

Peterson JD, Goldman MP, Weiss RA, Duffy DM, Fabi SG, Weiss MA, Guiha I (2012) Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline. Dermatol Surg 38:1–9CrossRef

30.

Parlar B, Blazek C, Cazzaniga S, Naldi L, Kloetgen HW, Borradori L, Buettiker U (2015) Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial. J Eur Acad Dermatol Venereol 29:549–554PubMedCrossRef

31.

Kakkos SK, Bountouroglou DG, Azzam M, Kalodiki E, Daskalopoulos M, Geroulakos G (2006) Effectiveness and safety of ultrasound-guided foam Sclerotherapy for recurrent varicose veins: immediate results. J Endovascular Ther 13:357–364CrossRef

32.

McDonagh B, Sorenson S, Gray C, Huntley DE, Putterman P, King T, Eaton T, Martin C, Harry JL, Cohen A, Guptan RC (2003) Clinical spectrum of recurrent postoperative varicose veins and efficacy of sclerotherapy management using the compass technique. Phlebology 18:173–186CrossRef

33.

Coleridge Smith P (2006) Chronic venous disease treated by ultrasound guided foam Sclerotherapy. Eur J Vasc Endovasc Surg 32:577–583PubMedCrossRef

34.

Coleridge Smith P (2009) Sclerotherapy and foam sclerotherapy for varicose veins. Phlebology 24:260–269PubMedCrossRef

35.

Bradbury AW, Bate G, Pang K, Darvall KA, Adam DJ (2010) Ultrasound-guided foam sclerotherapy is a safe and clinically effective treatment for superficial venous reflux. J Vasc Surg 52:939–945PubMedCrossRef

36.

Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury AW (2011) Duplex ultrasound outcomes following ultrasound guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins. Eur J Vasc Endovasc Surg 42:107–114PubMedCrossRef

37.

Darvall KA, Bate GR, Adam DJ, Silverman SH, Bradbury A (2011) Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins. Eur J Vasc Endovasc Surg 42:107–114PubMedCrossRef

38.

De Maeseneer M (2011) Surgery for recurrent varicose veins: toward a less-invasive approach? Perspect Vasc Surg Endovasc Ther 23:244–249PubMedCrossRef

39.

Pavei P, Vecchiato M, Spreafico G, Giraldi E, Ferrini M, Baccaglini U, Ancona E (2008) Natural history of recurrent varices undergoing reintervention: a retrospective study. Dermatol Surg 34:1676–1682PubMed

40.

Sukovatykh BS, Rodionov OA, Sukovatykh MB, Khodykin SP (2008) Diagnosis and treatment of atypical forms of varicose disease of pelvic veins. Vestnik Khirurgii Imeni Grekova 167:43–45

41.

Paraskevas P (2011) Successful ultrasound-guided foam sclerotherapy for vulval and leg varicosities secondary to ovarian vein reflux: a case study. Phlebology 26:29–31PubMedCrossRef

42.

Herwig R, Sansalone S (2015) Venous leakage treatment revisited: Pelvic venoablation using Aethoxysclerol under air block technique and valsalva maneuver. Arch Ital Urol Androl 87:1–4PubMedCrossRef

43.

Stücker M, Reich S, Hermes N, Altmeyer P (2006) Safety and efficiency of perilesional sclerotherapy in leg ulcer patients with postthrombotic syndrome and/or oral anticoagulation with phenprocoumon. J Dtsch Dermatol Ges 4:734–738PubMedCrossRef

44.

De Waard MM, Der Kinderen DJ (2005) Duplex ultrasonography-guided foam sclerotherapy of incompetent perforator veins in a patient with bilateral venous leg ulcers. Dermatol Surg 31:580–583PubMedCrossRef

45.

Hertzman PA, Owens R (2007) Rapid healing of chronic venous ulcers following ultrasound-guided foam sclerotherapy. Phlebology 22:34–39PubMedCrossRef

46.

Pang KH, Bate GR, Darvall KAL, Adam DJ, Bradbury AW (2010) Healing and recurrence rates following ultrasound guided foam sclerotherapy of superficial venous reflux in patients with chronic venous ulceration. Eur J Vasc Endovasc Surg 40:790–795PubMedCrossRef

47.

Williamsson C, Danielsson P, Smith L (2014) Catheter-directed foam sclerotherapy for chronic venous leg ulcers. Phlebology 29:688–693PubMedCrossRef

48.

Campos W, Torres IO, da Silva ES, Casella IB, Puech-Leão P (2015) A prospective randomized study comparing polidocanol foam sclerotherapy with surgical treatment of patients with primary chronic venous insufficiency and ulcer. Ann Vasc Surg 29:1128–1135PubMedCrossRef

49.

Lloret P, Redondo P, Cabrera J, Sierra A (2015) Treatment of venous leg ulcers with ultrasound-guided foam sclerotherapy: healing, long-term recurrence and quality of life evaluation. Wound Repair Regen 23:369–378PubMedCrossRef

50.

Neto FC, de Araújo GR, Kessler IM, de Amorim RFB, Falcão DP (2015) Treatment of severe chronic venous insufficiency with ultrasound-guided foam sclerotherapy: a two-year series in a single center in Brazil. Phlebology 30:113–118PubMedCrossRef

51.

Yamaki T, Nozaki M, Sasaki K (2000) Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 26:323–328PubMedCrossRef

52.

Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T (2008) Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 47:578–584PubMedCrossRef

53.

Blaise S, Charavin-Cocuzza M, Riom H, Brix M, Seinturier C, Diamand JM, Gachet G, Carpentier PH (2011) Treatment of low-flow vascular malformations by ultrasound-guided Sclerotherapy with Polidocanol foam: 24 cases and literature review. Eur J Vasc Endovasc Surg 41:412–417PubMedCrossRef

54.

Markovic JN, Kim CY, Lidsky ME, Shortell CK (2012) A 6‑year experience treating vascular malformations with foam Sclerotherapy. Perspect Vasc Surg Endovasc Ther 24:70–79PubMedCrossRef

55.

Van der Vleuten CJM, Kater A, Wijnen MHWA, Schultze Kool LJ, Rovers MM (2014) Effectiveness of Sclerotherapy, surgery, and laser therapy in patients with venous malformations: a systematic review. Cardiovasc Intervent Radiol 37:977–989PubMed

56.

Chen AW, Liu YR, Zhang K, Wang T, Liu SH (2015) Efficacy of sclerotherapy with radio-opaque foam guided by digital subtraction angiography for the treatment of complex venous malformations of the head and neck. Br J Oral Maxillofac Surg 53:809–813PubMedCrossRef

57.

Horbach SER, Lokhorst MM, Saeed P, De Pontouraude CMF, Rothova A, Van der Horst CMAM (2016) Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic Review of sclerosing agents. J Plast Reconstr Aesthet Surg 69(3):295–304PubMedCrossRef

58.

Kern P, Ramelet A‑A, Wutschert R, Bounameaux H, Hayoz D (2004) Single blind randomized study comparing chromated glycerin, polidocanol solution and polidocanol foam for treatment of telangiectactic leg veins. Dermatol Surg 30:367–372PubMed

59.

Rabe E, Pannier F, Gerlach H, Breu FX, Guggenbichler S, Wollmann JC (2008) Leitlinie Sklerosierungsbehandlung der Varikose. Phlebologie 37:27–34CrossRef

60.

Rao J, Wildemore JK, Goldmann MP (2005) Double-blind prospective comparative trial between foamed and liquid Polidocanol and Natrium Tetradecyl Sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg 31:631–635PubMedCrossRef

61.

Bullens-Goessens YIJM, Mentink LF et al (2004) Ultrasound-guided sclerotherapy of the insufficient short saphenous vein. Phlebol Ger 33:89–91CrossRef

62.

Schultz-Ehrenburg U, Tourbier H (1984) Doppler-kontrollierte Verödungsbehandlung der Vena saphena magna. Phlebol Proktol 13:117–122

63.

Vin F (1997) Principes de la Sclérothéraphie des Troncs Saphènes Internes. Phlebologie 50:229–234

64.

Gohel MS, Epstein DM, Davies AH (2010) Cost-effectiveness of traditional and endovenous treatments for varicose veins. Br J Surg 97:1815–1823PubMedCrossRef

65.

Biemans AAM, Kockaert M, Akkersdijk GP, van den Bos RR, de Maeseneer MGR, Cuypers P, Stijne T, Neumann MHA, Nijsten T (2013) Comparing endovenous laser ablation, foam sclerotherapy, and conventional surgery for great saphenous varicose veins. J Vasc Surg 58:727–734PubMedCrossRef

66.

Rasmussen L, Lawaetz M, Serup J, Bjoern L, Vennits B, Blemings A, Eklof B (2013) Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy, and surgical stripping for great saphenous varicose veins with 3‑year follow-up. J Vasc Surg Venous Lymphat Disord 1:349–356PubMedCrossRef

67.

Carroll C, Hummel S, Leaviss J, Re S, Stevens JW, Cantrell A, Michaels J (2015) Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins. Br J Surg 101:1040–1052CrossRef

68.

Nesbitt C, Bedenis R, Bhattacharya V, Stansby G (2014) Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005624.pub3CrossRefPubMed

69.

National Institute for Health and Care of Excellence (2013) Ultrasound-guided foam sclerotherapy for varicose veins. NICE interventional procedure guidance [IPG440]

70.

Siribumrungwong B, Noorit P, Wilasrusmee C, Leelahavarong P, Thakkinstian A, Teerawattananon Y (2016) Cost-utility analysis of great saphenous vein ablation with radiofrequency, foam and surgery in the emerging health-care setting of Thailand. Phlebology 31:573–581PubMedCrossRef

71.

Varisolve European Phase III Investigators Group, Wright D, Gobin JP, Bradbury AW et al (2006) Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial. Phlebology 21:180–190CrossRef

72.

Cavezzi A, Frullini A, Ricci S, Tessari L (2002) Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 17:13–18CrossRef

73.

Hamel-Desnos C, Ouvry P, Desnos P et al (2003) Sclérothérapie et thrombophilie: Démarche pour un consensus dans la sclérothérapie chez les thrombophiles. Phlebologie 56:165–169

74.

Gohel MS, Heatley F, Liu X, Bradbury A, Bulbulia R, Cullum N, Epstein DM, Nyamekye I, Poskitt KR, Renton S, Warwick J, Davies AH (2018) A randomized trial of early endovenous ablationin venous ulceration. N Eng J Med 378:2105–2114CrossRef

75.

Breu FX, Guggenbichler S, Wollmann JC (2008) 2nd European Consensus Meeting on Foam Sclerotherapy, 28–30 April 2006, Tegernsee, Germany. Vasa 37(Supplement 71):1–32PubMedCrossRef

76.

Guex JJ (2005) Les contre-indications de la sclérothérapie, mise à jour 2005. J Mal Vasc 30:144–149PubMedCrossRef

77.

Hamel-Desnos CM, Gillet J‑L, Desnos PR, Allaert FA (2009) Sclerotherapy of varicose veins in patients with documented thrombophilia: a prospective controlled randomized study of 105 cases. Phlebology 24:176–182PubMedCrossRef

78.

Gachet G, Spini L (2002) Sclérothérapie des varices sous anticoagulants. Phlebologie 55:41–44

79.

Rathbun S, Norris A, Stoner J (2012) Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders. Phlebology 27:105–117PubMedCrossRef

80.

Guex JJ, Allaert F‑A, Gillet J‑L (2005) Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 31:123–128PubMedCrossRef

81.

Guex JJ (2010) Complications of sclerotherapy: an update. Dermatol Surg 36:1056–1063PubMedCrossRef

82.

Munavalli GS, Weiss RA (2007) Complications of sclerotherapy. Semin Cutan Med Surg 26:22–28PubMedCrossRef

83.

Weiss RA, Weiss MA (1990) Incidence of side effects in the treatment of telangiectasias by compression Sclerotherapy: hypertonics saline vs. polidocanol. J Dermatol Surg Oncol 16:800–804PubMedCrossRef

84.

Gillet JL, Guedes JM, Guex JJ et al (2009) Side effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1025 patients. Phlebology 24:131–138PubMedCrossRef

85.

Cavezzi A, Parsi K (2012) Complications of foam sclerotherapy. Phlebology 27(Suppl 1):46–51PubMedCrossRef

86.

Sarvananthan T, Shepherd AC, Willenberg T, Davies AH (2012) Neurological complications of sclerotherapy for varicose veins. J Vasc Surg 55:243–251PubMedCrossRef

87.

Feied CF, Jackson JJ, Bren TS, Bond OB, Fernando CE, Young VC, Hashemiyoon RB (1994) Allergic reactions to Polidocanol for vein sclerosis. J Dermatol Surg Oncol 20:466–468PubMedCrossRef

88.

Pradalier A, Vincent D, Hentschel V et al (1995) Allergie aux sclérosants des varices. Rev Fr Allergol 35:440–443

89.

Hannaford PKP (2016) Intra-arterial injection of sclerosants: report of three cases treated with systemic steroids. Phlebology 31:241–250PubMedCrossRef

90.

Oesch A, Stirnemann P, Mahler F (1984) The acute Ischemic syndrome of the foot after Sclerotherapy of varicose veins. Schweiz Med Wochenschr 114:1155–1158PubMed

91.

Grommes J, Franzen EL, Binnebösel M, Toonder IM, Wittens C, Jacobs M, Greiner A (2010) Inadvertent arterial injection using catheter-assisted sclerotherapy resulting in amputation. Dermatol Surg 37:536–538PubMedCrossRef

92.

Hafner F, Fröhlich H, Gary T, Brodmann M (2013) Intra-arterial injection, a rare but serious complication of sclerotherapy. Phlebology 28:64–73PubMedCrossRef

93.

Goldman MP, Sadick NS, Weiss RA (1995) Cutaneous necrosis, telangiectatic matting and hyperpigmentation following Sclerotherapy. Dermatol Surg 21:19–29PubMedCrossRef

94.

Schuller-Petrović S, Brunner F, Neuhold N, Pavlović MD, Wölkart G (2011) Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy. J Eur Acad Dermatol Venereol 25:983–986PubMedCrossRef

95.

Bergan JJ, Weiss RA, Goldman MP (2000) Extensive tissue necrosis following high concentration sclerotherapy for varicose veins. Dermatol Surg 26:535–542PubMedCrossRef

96.

Bihari I, Magyar É (2001) Reasons for ulceration after injection treatment of telangiectasia. Dermatol Surg 27:133–136PubMed

97.

Geukens J, Rabe E, Bieber T (1999) Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol 9:132–133PubMed

98.

Ramelet AA, Parmentier L (2010) Delayed Nicolau’s Livedoid dermatitis after ultrasound-guided Sclerotherapy. Dermatol Surg 36:155–158PubMedCrossRef

99.

Van der Plas JPL, Lambers JC, van Wersch JW, Koehler PJ (1994) Reversible ischaemic neurological deficit after sclerotherapy of varicose veins. Lancet 343:428PubMedCrossRef

100.

Künzelberger B, Pieck C, Altmeyer P, Stücker M (2006) Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1 % polidocanol. Derm Surg 32:1410

101.

Hill DA (2014) Neurological and chest symptoms following sclerotherapy: a single centre experience. Phlebology 29:619–627PubMedCrossRef

102.

Willenberg T, Smith PC, Shepherd A, Davies AH (2013) Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review. Phlebology 28:123–131PubMedCrossRef

103.

Parsi K (2012) Paradoxical embolism, stroke and sclerotherapy. Phlebology 27:147–167PubMedCrossRef

104.

Parsi K (2011) Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications. Phlebology 26:140–147PubMedCrossRef

105.

Morrison N, Cavezzi A, Bergan J, Partsch H (2006) Regarding “stroke after varicose vein foam injection sclerotherapy”. J Vasc Surg 44:224–225PubMedCrossRef

106.

Passariello F (2007) Sclerosing foam and patent foramen ovale. The final report. In: Word Congress of the International Union of Phlebology; Int Angiol, Bd. 26, S 87

107.

Wagdi P (2006) Migräne und offenes Foramen Ovale: nur ein vorübergehender Hoffnungsschimmer? Kardiovasc Med 9:32–36

108.

Gillet JL, Donnet A, Lausecker M, Guedes JM, Guex JJ, Lehmann P (2010) Pathophysiology of visual disturbances occurring after foam sclerotherapy. Phlebology 25:261–266PubMedCrossRef

109.

Zouitina TM, Hyra M, Seryer D, Chillon J‑M, Bugnicourt J‑M (2014) Prolonged acute migraine with aura and reversible brain MRI abnormalities after liquid sclerotherapy. J Headache Pain 15:1–4CrossRef

110.

Frullini A, Felice F, Burchielli S, Di Stefano R (2011) High production of endothelin after foam sclerotherapy: a new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy. Phlebology 26:203–208PubMedCrossRef

111.

Frullini A, Barsotti MC, Santoni T, Duranti E, Burchielli S, Di Stefano R (2012) Significant endothelin release in patients treated with foam sclerotherapy. Dermatol Surg 38:741–747PubMedCrossRef

112.

Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T (2008) Multiple Small-Dose Injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins. Eur J Vasc Endovasc Surg 37:343–348PubMedCrossRef

113.

Forlee MV, Grouden M, Moore DJ, Shanik G (2006) Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg 43:162–164PubMedCrossRef

114.

Busch RG, Derrick M, Manjoney D (2008) Major neurological events following foam sclerotherapy. Phlebology 23:189–192CrossRef

115.

Leslie-Mazwi TM, Avery LL, Sims JR (2009) Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy. Neurocrit Care 11:97–100PubMedCrossRef

116.

De Laney MC, Bowe CT, Higgins GL III (2010) Acute stroke from air embolism after leg Sclerotherapy. West J Emerg Med 11:397

117.

Ma RWL, Pilotelle A, Paraskevas P, Parsi K (2011) Three cases of stroke following peripheral venous interventions. Phlebology 26:280–284PubMedCrossRef

118.

Harzheim M, Becher H, Klockgether T (2000) Brain infarct from a paradoxical embolism following a varices operation. Dtsch Med Wochenschr 125:794–796PubMedCrossRef

119.

Caggiati A, Franceschini M (2010) Stroke following endovenous laser treatment of varicose veins. J Vasc Surg 51:218–220PubMedCrossRef

120.

Gillet JL (2011) Neurological complications of foam sclerotherapy: fears and reality. Phlebology 26:277–279PubMedCrossRef

121.

Deichman B, Blum G (1995) Cerebrovascular accident after sclerotherapy. Phlebologie 24:148–152

122.

Kas A, Begue M, Nifle C, Gil R, Neau JP (2000) Infarctus cérébelleux après sclérothérapie de varicosités des membres inférieurs. Presse Med 29:1935PubMed

123.

Hanisch F, Müller T, Krivocuca M, Winterholler M (2004) Stroke following variceal sclerotherapy. Eur J Med Res 9:282–284PubMed

124.

Picard C, Deltombe B, Duru C, Godefroy O, Bugnicourt JM (2010) Foam sclerotherapy: a possible cause of ischaemic stroke? J Neurol Neurosurg Psychiatry 81:582–583PubMedCrossRef

125.

Hahn M, Shulz T, Juenger M (2010) Late stroke after foam sclerotherapy. Vasa 39:108–110PubMedCrossRef

126.

Guex JJ (1996) Thombotic complications of the varicose disease. J Dermatol Surg 22:378–382

127.

Hamel-Desnos C, Desnos P, Ferré B, Le Querrec A (2011) In vivo biological effects of foam sclerotherapy. Eur J Vasc Endovasc Surg 42:238–245PubMedCrossRef

128.

Fabi SG, Peterson JD, Goldman MP, Guiha I (2012) An investigation of coagulation cascade activation and induction of Fibrinolysis using foam Sclerotherapy of reticular veins. Dermatol Surg 38:367–372PubMedCrossRef

129.

Jia X, Mowatt G, Burr JM, Cassar K, Cooke J, Fraser C (2007) Systematic review of foam sclerotherapy for varicose veins. Br J Surg 94:925–936PubMedCrossRef

130.

Dermody M, Schul MW, O’Donnell TF (2015) Thromboembolic complications of endovenous thermal ablation and foam sclerotherapy in the treatment of great saphenous vein insufficiency. Phlebology 30:357–364PubMedCrossRef

131.

Myers KA, Jolley D (2008) Factors affecting the risk of deep venous occlusion after ultrasound-guided Sclerotherapy for varicose vein. Eur J Vasc Endovasc Surg 36:602–605PubMedCrossRef

132.

Reich-Schupke S, Doerler M, Altmeyer P, Stücker M (2013) Foam sclerotherapy with enoxaparin prophylaxis in high-risk patients with postthrombotic syndrome. Vasa 42:50–55PubMedCrossRef

133.

Zipper SG (2000) Nervus peronäus-Schaden nach Varizensklerosierung mit Aethoxysklerol. Versicherungsmedizin 4:185–187

134.

Reich-Schupke S, Weyer K, Altmeyer P, Stücker M (2010) Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam. Vasa 39:169–174PubMedCrossRef

135.

Georgiev MJ (1990) Postsclerotherapy hyperpigmentations: a one-year follow-up. Dermatol Surg Oncol 16:608–610CrossRef

136.

Scultetus AH, Villavicencio JL, Kao TC, Gillespie DL, Ketron GD, Iafrati MD, Pikoulis E, Eifert S (2003) Microthrombectomy reduces postsclerotherapy pigmentation: multicenter randomized trial. J Vasc Surg 38:896–903PubMedCrossRef

137.

Goldman MP, Kaplan RP, Duffy DM (1987) Postsclerotherapy hyperpigmentation: a histologic evaluation. J Dermatol Surg Oncol 13:547–550PubMedCrossRef

138.

Davis LT, Duffy DM (1990) Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment. J Dermatol Surg Oncol 16:327–330PubMedCrossRef

139.

Ramelet A‑A (2010) Phlébologie esthétique. Télangiectasies : possibilités thérapeutiques. Cosmétologie et Dermatologie esthétique. EMC (Elsevier Masson SAS), Paris

140.

Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E, Salles-Cunha SX (2008) Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation. J Vasc Surg 47:830–836PubMedCrossRef

141.

Morrison N, Neuhardt DL, Rogers CR, McEown J, Morrison T, Johnson E, Salles-Cunha SX (2010) Incidence of side effects using carbon dioxide oxygen foam for chemical ablation of superficial veins of the lower extremity. Eur J Vasc Endovasc Surg 40:407–413PubMedCrossRef

142.

Beckitt T, Elstone A, Ashley S (2011) Air versus physiological gas for ultrasound guided foam Sclerotherapy treatment of varicose veins. Eur J Vasc Endovasc Surg 42:115–119PubMedCrossRef

143.

Hesse G, Breu FX, Kuschmann A, Hartmann K, Salomon N (2012) Sclerotherapy using air- or CO2-O2-foam: post-approval study. Phlebologie 41:77–88CrossRef

144.

Mercer KG, Scott DJ, Berridge DC (1998) Preoperative duplex imaging is required before all operations for primary varicose veins. Br J Surg 85:1495–1497PubMedCrossRef

145.

Blomgren L, Johansson G, Bergquist D (2005) Randomized clinical trial of routine preoperative duplex imaging before varicose vein surgery. Br J Surg 92:688–694PubMedCrossRef

146.

Coleridge-Smith P, Labropoulos N, Partsch H, Myers K, Nicolaides A, Cavezzi A (2006) Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs—UIP consensus document. Part I. Basic principles. Eur J Vasc Endovasc Surg 31:83–92PubMedCrossRef

147.

De Maeseneer M, Pichot O, Cavezzi A, Earnshaw J, van Rij A, Lurie F, Smith PC (2011) Duplex ultrasound investigation of the veins of the lower limbs after treatment for varicose veins—UIP consensus document. Eur J Vasc Endovasc Surg 42:89–102PubMedCrossRef

148.

Rautio T, Perälä J, Biancari F, Wiik H, Ohtonen P, Haukipuro K, Juvonen T (2002) Accuracy of hand-held Doppler in planning the operation for primary varicose veins. Eur J Vasc Endovasc Surg 24:450–455PubMedCrossRef

149.

Franco G (1998) Explorations ultrasonographiques des récidives variqueuses post-chirurgicales. Phlebologie 51:403–413

150.

Jiang P, van Rij AM, Christie R, Hill G, Solomon C, Thomson I (1999) Recurrent varicose veins: patterns of reflux and clinical severity. Cardiovasc Surg 7:332–339PubMedCrossRef

151.

Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH (2003) Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg 37:533–538PubMedCrossRef

152.

Bihari I, Tasnadi G, Bihari P (2003) Importance of subfascial collaterals in deep-vein malformations. Dermatol Surg 29:146–149PubMed

153.

Brunken A, Rabe E, Pannier F (2009) Changes in venous function after foam sclerotherapy of varicose veins. Phlebology 24:145–150PubMedCrossRef

154.

Darvall KAL, Sam RC, Bate GR, Adam DJ, Bradbury AW (2010) Photoplethysmographic venous refilling times following ultrasound guided foam Sclerotherapy for symptomatic superficial venous reflux: relationship with clinical outcomes. Eur J Vasc Endovasc Surg 40:267–272PubMedCrossRef

155.

Kreussler: Fachinformationen Aethoxysklerol® 0,25 %/0,5 %/1 %/2 %/3 % Stand August 2015, Chemische Fabrik Kreussler & Co GmbH

156.

Wollmann JC (2004) The history of sclerosing foams. Dermatol Surg 30:694–703PubMed

157.

Sadoun S, Benigni JP, Sica M (2002) Étude prospective de l’efficacité de la mousse de sclérosant dans le traitement des varices tronculaires des membres inférieurs. Phlebologie 55:259–262

158.

Tessari L, Cavezzi A, Frullini A (2001) Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 27:58–60PubMed

159.

De Roos KP, Groen L, Leenders AC (2011) Foam sclerotherapy: investigating the need for sterile air. Dermatol Surg 37:1119–1124PubMedCrossRef

160.

Guex JJ, Hamel-Desnos C, Gillet JL, Chleir F, Perrin M (2008) Sclérothérapie des varices par mousse écho-guidée: techniques de mise en œuvre, indications, résultats publiés. Phlebologie 61:261–270

161.

Yamaki T, Hamahata A, Soejima K, Kono T, Nozaki M, Sakurai H (2012) Prospective randomised comparative study of visual foam Sclerotherapy alone or in combination with ultrasound-guided foam sclerotherapy for treatment of superficial venous insufficiency: preliminary report. Eur J Vasc Endovasc Surg 43:343–347PubMedCrossRef

162.

Blaise S, Bosson JL, Diamand JM (2010) Ultrasound-guided sclerotherapy of the great saphenous vein with 1 % vs. 3 % Polidocanol foam: a multicentre double-blind randomised trial with 3‑year follow-up. Eur J Vasc Endovasc Surg 39:779–786PubMedCrossRef

163.

Ceulen RPM, Bullens-Goessens YIJM, Pi-Van De Venne SJA (2007) Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1 % versus 3 % Polidocanol foam: Results of a randomized controlled trial with 1‑year follow-up. Dermatol Surg 33:276–281PubMed

164.

Yamaki T, Nozaki M, Iwasaka S (2004) Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 30:718–722PubMed

165.

Kanter A, Thibault P (1996) Saphenofemoral incompetence treated by ultrasound-guided sclerotherapy. Dermatol Surg 22:648–652PubMed

166.

Grondin L, Young R, Wouters L (1997) Sclérothérapie écho-guidée et sécurité: comparaison des techniques. Phlebologie 50:241–245

167.

Schadeck M, Allaert FA (1997) Résultats à long terme de la Sclérothérapie des Saphènes internes. Phlebologie 50(2):257–262

168.

Elias S, Raines JK (2012) Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. Phlebology 27:67–72PubMedPubMedCentralCrossRef

169.

Whiteley MS, Dos SSJ, Lee CT, Li JM (2017) Mechanochemical ablation causes endothelial and medial damage to the vein wall resulting in deeper penetration of sclerosant compared with sclerotherapy alone in extrafascial great saphenous vein using an ex vivo model. J Vasc Surg Venous Lymphat Disord 5:370–377PubMedCrossRef

170.

National Institute for Health and Care Excellence (2016) Interventional procedure overview of endovenous mechanochemical ablation for varicose veins. NICE, London (https://www.nice.org.uk/guidance/ipg557/documents/overview.)

171.

Mechanochemical Venous Ablation for Varicose Veins (2017) Center for evidence-based policy. Oregon Health & Science University, Portland (www.ohsu.edu/policycenter)

172.

Ramon R, van Eekeren JP, Boersma D, Konijn V, de Vries JP, Reijnen MM (2013) Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. J Vasc Surg 57:445–450CrossRef

173.

Khor SN, Kam JW, Kum S, Tan YK, Tang TY (2018) ClariVein™—One year results of mechano-chemical ablation for varicose veins in a multi-ethnic Asian population from Singapore. Phlebology. https://doi.org/10.1177/0268355518771225CrossRefPubMed

174.

van Eekeren RR, Boersma D, Konijn V, de Vries JP, Reijnen MM (2013) Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. J Vasc Surg 57:445–450PubMedCrossRef

175.

Witte ME, Holewijn S, van Eekeren RR, de Vries JP, Zeebregts CJ, Reijnen MM (2017) Midterm outcome of mechanochemical endovenous ablation for the treatment of great Saphenous vein insufficiency. J Endovasc Ther 24:149–155PubMedCrossRef

176.

Lane T, Bootun R, Dharmarajah B, Lim CS, Najem M, Renton S, Sritharan K, Davies AH (2017) A multi-centre randomised controlled trial comparing radiofrequency and mechanical occlusion chemically assisted ablation of varicose veins—Final results of the Venefit versus Clarivein for varicose veins trial. Phlebology 32:89–98PubMedCrossRef

177.

Devereux N, Recke AL, Westermann L, Recke A, Kahle B (2014) Catheter-directed foam Sclerotherapy of great Saphenous veins in combination with pre-treatment reduction of the diameter employing the principals of perivenous tumescent local anesthesia. Eur J Vasc Endovasc Surg 47:187–195PubMedCrossRef

178.

Ceulen RPM, Jagtmann EA, Sommer A, Teule GJJ, Schurink GWH, Kemerink GJ (2010) Blocking the saphenafemoral junction during ultrasound guided foam sclerotherapy—assessment of a presumed safety-measure procedure. Eur J Vasc Endovasc Surg 40:772–776PubMedCrossRef

179.

Brodersen JP (2007) Catheter-assisted vein sclerotherapy: a new approach for sclerotherapy of the greater saphenous vein with a double-lumen balloon catheter. Dermatol Surg 33:469–475PubMed

180.

Wildenhues B (2005) Catheter-assisted foam sclerotherapy. A new minimally invasive method for the treatment of trunk varicosis of the long and short saphenous veins. Phlebologie 34:165–170CrossRef

181.

Hahn M, Schulz T, Jünger M (2007) Sonographically guided, transcatheter foam sclerotherapy of the great saphenous vein. Medical and oeconomic aspects. Phlebologie 36:309–312CrossRef

182.

Bidwai A, Beresford T, Dialynas M, Prionidis J, Panayiotopoulos Y, Bowne TF (2007) Balloon control of the saphenofemoral junction during foam sclerotherapy : proposed innovation. J Vasc Surg 46:145–147PubMedCrossRef

183.

Kölbel T, Hinchliffe RJ, Lindbal B (2007) Catheter-directed foam sclerotherapy of axial saphenous reflux. Early results. Phlebology 22:219–222PubMedCrossRef

184.

Parsi K (2009) Catheter-directed sclerotherapy. Phlebology 24:98–107PubMedCrossRef

185.

Cavezzi A, Tessari L (2009) Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection. Phlebology 24:247–251PubMedCrossRef

186.

Chapman-Smith P, Browne A (2009) Prospective five year study of ultrasound guided foam sclerotherapy in the treatment of great saphenous vein reflux. Phlebology 24:183–188PubMedCrossRef

187.

Kern P, Ramelet AA, Wütschert R, Hayoz D (2007) Compression after sclerotherapy for telangiectasiastelangiectasias and reticular leg veins. A randomized controlled study. J Vasc Surg 45:1212–1216PubMedCrossRef

188.

Weiss RA, Sadick NS, Goldman MP, Weiss MA (1999) Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg 25:105–108PubMedCrossRef

189.

Goldman MP, Beaudoing D, Marley W, Lopez L, Butie A (1990) Compression in the treatment of leg teleangiectasia: a preliminary report. J Dermatol Surg Oncol 16:322–325PubMedCrossRef

190.

Nootheti PK, Cadag KM, Magpantay A, Goldman MP (2009) Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins. Dermatol Surg 35:53–58PubMed

191.

Hamel-Desnos C, Guias BJ, Desnos PR, Mesgard A (2010) Foam sclerotherapy of the saphenous veins. Randomised controlled trial with or without compression. Eur J Vasc Endovasc Surg 39:500–507PubMedCrossRef

192.

El-Sheikha J, Carradice D, Nandhra S, Leung HC, Smith GE, Campbell B, Chetter IC (2015) Systematic review of compression following treatment for varicose veins. Br J Surg 102:719–725PubMedCrossRef

193.

Zarca C, Bailly C, Gachet G, Spini L (2012) ClassMousse 1 study: compression hosiery and foam Sclerotherapy. Phlebologie 65:11–20

194.

Ferrara F, Bernbach HR (2009) La compression écho-guidée après sclérothérapie. Phlebologie 62:36–41

195.

Stanley PRW, Bickerton DR, Campbell WB (1991) Injection sclerotherapy for varicose veins—a comparison of materials for applying local compression. Phlebology 6:37–39CrossRef

196.

Friedmann DP, Liolios AM, Wu DC, Goldman MP, Eimpunth S (2015) A randomized, double-blind, placebo-controlled study of the effect of a high-potency topical corticosteroid after Sclerotherapy for reticular and telangiectatic veins of the lower extremities. Dermatol Surg 41:1158–1163PubMedCrossRef

Titel: Leitlinie Sklerosierungsbehandlung der Varikose
S2k-Leitlinie der Deutschen Gesellschaft für Phlebologie (DGP) in Kooperation mit folgenden Fachgesellschaften: DDG, DGA, DGG, BVP
verfasst von: Prof. Dr. med. E. Rabe
F. X. Breu
I. Flessenkämper
H. Gerlach
S. Guggenbichler
B. Kahle
R. Murena
S. Reich-Schupke
T. Schwarz
Prof. Dr. med. M. Stücker
E. Valesky
S. Werth
F. Pannier
Publikationsdatum: 05.11.2020
Verlag: Springer Medizin
Schlagwörter: Varikosis
Sklerosierung
Varikosis
Varikosis
Erschienen in: Die Dermatologie / Ausgabe 1/2021
Print ISSN: 2731-7005
Elektronische ISSN: 2731-7013
DOI: https://doi.org/10.1007/s00105-020-04707-y

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

16.04.2024 | Infektiologie | Nachrichten

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Leitlinie Sklerosierungsbehandlung der Varikose

S2k-Leitlinie der Deutschen Gesellschaft für Phlebologie (DGP) in Kooperation mit folgenden Fachgesellschaften: DDG, DGA, DGG, BVP

Auszug

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Dupilumab ist mit kutanen T-Zell-Lymphomen assoziiert

Chemotherapie mit Hindernissen

Update Dermatologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

UV-Phototherapie und Photodiagnostik – eine praktische Übersicht

Fokaler Haarverlust bei einem blondhaarigen Jungen – Diagnose mittels Trichoskopie

Ist die Kompressionstherapie bei Erysipel des Unterschenkels kontraindiziert?

Von genetischen Varianten zur Pathophysiologie? – Genomweite Assoziationsstudie beim malignen Melanom

Photodermatologie

Antinukleäre Antikörper

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Dupilumab ist mit kutanen T-Zell-Lymphomen assoziiert

Chemotherapie mit Hindernissen

Update Dermatologie